Cardlytics (NASDAQ: CDLX) reported Q4 EPS of ($0.06), $0.11 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $47.8 million versus the consensus estimate of $45.77 million.

“Our strong fourth quarter results cap off an exciting and transformational year for Cardlytics, having completed our IPO in February 2018 and solidifying agreements with both the number one and the number three largest banks in the U.S. to launch Cardlytics Direct,” said Scott Grimes, CEO & Co-Founder of Cardlytics. “We believe our scale, unique capabilities, and ongoing investments in our business will enable us to deliver increased value to our clients, our bank partners and their customers.”

“In 2018, we built the foundation and the scale to support sustained growth for years to come,” said Lynne Laube, COO & Co-Founder of Cardlytics. “In 2019, we are focused on monetizing this scale, leveraging our expertise to provide actionable insights for our marketer clients, reach the most likely buyers in a brand-safe channel, then measure, to the penny, the return on their marketing investment.”

Fourth Quarter 2018 Financial Results

• Total revenue was $47.8 million, an increase of 21.8% year-over-year, compared to $39.3 million in the fourth quarter of 2017.
• Cardlytics Direct revenue was $47.7 million, an increase of 23.0%, compared to $38.8 million in the fourth quarter of 2017.
• GAAP net loss attributable to common stockholders was $(11.6) million, or $(0.53) per diluted share, based on 21.8 million weighted-average common shares outstanding, compared to a loss of $(4.4) million, or $(1.26) per diluted share, based on 3.5 million weighted-average common shares outstanding in the fourth quarter of 2017.
• Non-GAAP net loss was $(1.3) million, or $(0.06) per diluted share, based on 21.8 million non-GAAP weighted-average common shares outstanding, compared to a loss of $(2.6) million, or $(0.18) per diluted share, based on 14.1 million non-GAAP weighted-average common shares outstanding in the fourth quarter of 2017.
• Adjusted contribution, a non-GAAP metric, was $22.1 million an increase of 26.7% compared to $17.4 million in the fourth quarter of 2017.
• Adjusted EBITDA, a non-GAAP metric, was a gain of $0.3 million compared to a gain of $0.5 million in the fourth quarter of 2017.

“Our fourth quarter and 2018 growth came in large part from growth in budgets from existing and new marketers,” said David Evans, CFO of Cardlytics. “Between the positive trends we’re already seeing in longer-term and larger contracts from marketers this year, and our continued FI MAU growth, we’re excited about our prospects for 2019.”

GUIDANCE:

Cardlytics sees Q1 2019 revenue of $34.5-36.5 million, versus the consensus of $41.79 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.